Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic

Identifieur interne : 001817 ( Main/Exploration ); précédent : 001816; suivant : 001818

Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic

Auteurs : Carolyn M. Hendrickson [États-Unis] ; Michael A. Matthay [États-Unis]

Source :

RBID : PMC:4045622

Descripteurs français

English descriptors

Abstract

Acute viral pneumonia is an important cause of acute lung injury (ALI), although not enough is known about the exact incidence of viral infection in ALI. Polymerase chain reaction-based assays, direct fluorescent antigen (DFA) assays, and viral cultures can detect viruses in samples from the human respiratory tract, but the presence of the virus does not prove it to be a pathogen, nor does it give information regarding the interaction of viruses with the host immune response and bacterial flora of the respiratory tract. The severe acute respiratory syndrome (SARS) epidemic and the 2009 H1N1 influenza pandemic provided a better understanding of how viral pathogens mediate lung injury. Although the viruses initially infect the respiratory epithelium, the relative role of epithelial damage and endothelial dysfunction has not been well defined. The inflammatory host immune response to H1N1 infection is a major contributor to lung injury. The SARS coronavirus causes lung injury and inflammation in part through actions on the nonclassical renin angiotensin pathway. The lessons learned from the pandemic outbreaks of SARS coronavirus and H1N1 capture key principles of virally mediated ALI. There are pathogen-specific pathways underlying virally mediated ALI that converge onto a common end pathway resulting in diffuse alveolar damage. In terms of therapy, lung protective ventilation is the cornerstone of supportive care. There is little evidence that corticosteroids are beneficial, and they might be harmful. Future therapeutic strategies may be targeted to specific pathogens, the pathogenetic pathways in the host immune response, or enhancing repair and regeneration of tissue damage.


Url:
DOI: 10.1055/s-0033-1351122
PubMed: 23934716
PubMed Central: 4045622


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic</title>
<author>
<name sortKey="Hendrickson, Carolyn M" sort="Hendrickson, Carolyn M" uniqKey="Hendrickson C" first="Carolyn M." last="Hendrickson">Carolyn M. Hendrickson</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, California</nlm:aff>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Matthay, Michael A" sort="Matthay, Michael A" uniqKey="Matthay M" first="Michael A." last="Matthay">Michael A. Matthay</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, California</nlm:aff>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">23934716</idno>
<idno type="pmc">4045622</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045622</idno>
<idno type="RBID">PMC:4045622</idno>
<idno type="doi">10.1055/s-0033-1351122</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">000D43</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000D43</idno>
<idno type="wicri:Area/Pmc/Curation">000D43</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000D43</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000929</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000929</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:23934716</idno>
<idno type="wicri:Area/PubMed/Corpus">001150</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001150</idno>
<idno type="wicri:Area/PubMed/Curation">001150</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001150</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001068</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001068</idno>
<idno type="wicri:Area/Ncbi/Merge">002727</idno>
<idno type="wicri:Area/Ncbi/Curation">002727</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002727</idno>
<idno type="wicri:doubleKey">1069-3424:2013:Hendrickson C:viral:pathogens:and</idno>
<idno type="wicri:Area/Main/Merge">001823</idno>
<idno type="wicri:Area/Main/Curation">001817</idno>
<idno type="wicri:Area/Main/Exploration">001817</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic</title>
<author>
<name sortKey="Hendrickson, Carolyn M" sort="Hendrickson, Carolyn M" uniqKey="Hendrickson C" first="Carolyn M." last="Hendrickson">Carolyn M. Hendrickson</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, California</nlm:aff>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Matthay, Michael A" sort="Matthay, Michael A" uniqKey="Matthay M" first="Michael A." last="Matthay">Michael A. Matthay</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, California</nlm:aff>
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Seminars in respiratory and critical care medicine</title>
<idno type="ISSN">1069-3424</idno>
<idno type="eISSN">1098-9048</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acute Lung Injury (diagnosis)</term>
<term>Acute Lung Injury (epidemiology)</term>
<term>Acute Lung Injury (virology)</term>
<term>Animals</term>
<term>Disease Outbreaks</term>
<term>Fluorescent Antibody Technique, Direct</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Polymerase Chain Reaction (methods)</term>
<term>SARS Virus (isolation & purification)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Flambées de maladies</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Lésion pulmonaire aigüe (diagnostic)</term>
<term>Lésion pulmonaire aigüe (virologie)</term>
<term>Lésion pulmonaire aigüe (épidémiologie)</term>
<term>Pneumopathie virale ()</term>
<term>Réaction de polymérisation en chaîne ()</term>
<term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Technique d'immunofluorescence directe</term>
<term>Virus du SRAS (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Acute Lung Injury</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Lésion pulmonaire aigüe</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Acute Lung Injury</term>
<term>Influenza, Human</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Lésion pulmonaire aigüe</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Acute Lung Injury</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Lésion pulmonaire aigüe</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Disease Outbreaks</term>
<term>Fluorescent Antibody Technique, Direct</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Pneumopathie virale</term>
<term>Réaction de polymérisation en chaîne</term>
<term>Technique d'immunofluorescence directe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">Acute viral pneumonia is an important cause of acute lung injury (ALI), although not enough is known about the exact incidence of viral infection in ALI. Polymerase chain reaction-based assays, direct fluorescent antigen (DFA) assays, and viral cultures can detect viruses in samples from the human respiratory tract, but the presence of the virus does not prove it to be a pathogen, nor does it give information regarding the interaction of viruses with the host immune response and bacterial flora of the respiratory tract. The severe acute respiratory syndrome (SARS) epidemic and the 2009 H1N1 influenza pandemic provided a better understanding of how viral pathogens mediate lung injury. Although the viruses initially infect the respiratory epithelium, the relative role of epithelial damage and endothelial dysfunction has not been well defined. The inflammatory host immune response to H1N1 infection is a major contributor to lung injury. The SARS coronavirus causes lung injury and inflammation in part through actions on the nonclassical renin angiotensin pathway. The lessons learned from the pandemic outbreaks of SARS coronavirus and H1N1 capture key principles of virally mediated ALI. There are pathogen-specific pathways underlying virally mediated ALI that converge onto a common end pathway resulting in diffuse alveolar damage. In terms of therapy, lung protective ventilation is the cornerstone of supportive care. There is little evidence that corticosteroids are beneficial, and they might be harmful. Future therapeutic strategies may be targeted to specific pathogens, the pathogenetic pathways in the host immune response, or enhancing repair and regeneration of tissue damage.</p>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Hendrickson, Carolyn M" sort="Hendrickson, Carolyn M" uniqKey="Hendrickson C" first="Carolyn M." last="Hendrickson">Carolyn M. Hendrickson</name>
</region>
<name sortKey="Matthay, Michael A" sort="Matthay, Michael A" uniqKey="Matthay M" first="Michael A." last="Matthay">Michael A. Matthay</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001817 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001817 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4045622
   |texte=   Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23934716" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021